ADCYAP1 and cyclic hematopoiesis: Conclusion: This large‐scale study demonstrated increased PACAP‐38 levels in all disease states of CH compared to headache‐free controls, strengthening the hope of a possible effect of PACAP‐38‐targeting treatment in future trials.